Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients

BACKGROUND: Critical coronavirus disease 2019 (COVID-19) has a high fatality rate, especially in hemodialysis (HD) patients, with this poor prognosis being caused by systemic hyperinflammation; cytokine storms. Steroid pulse therapy or tocilizumab (TCZ) have insufficient inhibitory effects against c...

Descripción completa

Detalles Bibliográficos
Autores principales: Toda, Masataro, Fujii, Kentaro, Yoshifuji, Ayumi, Kondo, Yasushi, Itoh, Kazuto, Sekine, Kazuhiko, Kikuchi, Takahide, Ryuzaki, Munekazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390024/
https://www.ncbi.nlm.nih.gov/pubmed/34436742
http://dx.doi.org/10.1007/s10157-021-02126-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390024/
https://www.ncbi.nlm.nih.gov/pubmed/34436742
http://dx.doi.org/10.1007/s10157-021-02126-4

Ejemplares similares